A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/216 (2006.01) A61K 31/192 (2006.01) A61P 37/06 (2006.01)
Patent
CA 2432432
The use of (R).-ibuprofen methanesulfonamide is described for the preparation of medicaments for the treatment and prevention of functional injury resulting from rejection reactions of transplanted organs. In particular, the use of non- toxic salts of (R)-ibuprofen methanesulfonamide, such as the (L)-lysine salt, is described for the prevention and the treatment of rejection reactions of transplanted kidneys.
La présente invention concerne l'utilisation de (R)-ibuprofène méthane sulfonamide pour préparer des médicaments permettant le traitement et la prévention des lésions fonctionnelles résultant de réactions de rejet à la suite de transplantations d'organes. En particulier, l'invention a pour objet l'utilisation de sels non toxiques de (R)-ibuprofène méthane sulfonamide, tels que le sel de (L)-lysine, pour la prévention et le traitement des réactions de rejet à la suite de la transplantation de reins.
Bertini Riccardo
Colotta Francesco
Novellini Roberto
Dompe Pha.r.ma S.p.a.
Dompe S.p.a.
Kirby Eades Gale Baker
LandOfFree
Use of (r)-ibuprofen methanesulfonamide and salts thereof in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of (r)-ibuprofen methanesulfonamide and salts thereof in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of (r)-ibuprofen methanesulfonamide and salts thereof in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1729779